C1QTNF3 and rheumatoid arthritis: Since the circulating level of CTRP3 in patients with RA has yet not been evaluated, this study's main purpose was to investigate the effect of silymarin on the serum level of CTRP3 and to find possible new mutations in the CTRP3 gene to be considered in prospective genotyping studies.